A Study of Ixabepilone as Second-line Therapy for Locally Advanced, Recurrent, or Metastatic Endometrial Cancer
Stopped early · Phase 3
Conditions studied: Endometrial Cancer
In brief
The primary purpose of this study is to investigate whether administration of ixabepilone results in superior outcome as assessed by overall survival compared with that achieved with standard chemotherapy (paclitaxel or doxorubicin) in women with advanced endometrial cancer that has progressed following first-line chemotherapy.
Key facts
- Study ID
- NCT00883116
- Run by
- R-Pharm
- People needed
- 551
- Starts
- 2009-08-01
- Expected to finish
- 2014-02-01
- Last updated by the study team
- 2017-03-09
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Rocky Mountain Gynecologic Oncology — Englewood, Colorado, United States
- Peter E. Schwartz, Md — New Haven, Connecticut, United States
- Hematology Oncology, P.C. — Stamford, Connecticut, United States
- Gynecologic Oncology Assoc.,Inc — Hollywood, Florida, United States
- Florida Hospital Cancer Institute — Orlando, Florida, United States
- Sarasota Memorial Health Care System — Sarasota, Florida, United States
- H. Lee Moffitt Cancer Center — Tampa, Florida, United States
- Georgia Health Science University — Augusta, Georgia, United States
- Sudarshan K. Sharma, Md — Hinsdale, Illinois, United States
- Central Dupage Hospital Cancer Center — Warrenville, Illinois, United States
- St. Vincent Hospital And Health Care Center, Inc. — Indianapolis, Indiana, United States
- Hematology And Oncology Specialists, Llc — Marrero, Louisiana, United States
- Women'S Health Specialists — Rockville, Maryland, United States
- Sparrow Regional Cancer Center — Lansing, Michigan, United States
- University Of Minnesota — Minneapolis, Minnesota, United States
- Saint Dominic's Gynecologic Oncology — Jackson, Mississippi, United States
- Matthew A Powell, Md — St Louis, Missouri, United States
- Blumenthal Cancer Center — Charlotte, North Carolina, United States
- Duke University Medical Center — Durham, North Carolina, United States
- Peggy And Charles Stephenson Oklahoma Cancer Center — Oklahoma City, Oklahoma, United States
- Tulsa Cancer Institute — Tulsa, Oklahoma, United States
- Pennsylvania Oncology Hematology Associates — Philadelphia, Pennsylvania, United States
- Magee-Womens Hospital Of Upmc Laboratory — Pittsburgh, Pennsylvania, United States
- Women & Infants Hospital Of Ri — Providence, Rhode Island, United States
- University Of South Alabama — Mobile, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.